<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2020-10-07" version="199">
<accession>Q9GZV9</accession>
<accession>Q4V758</accession>
<name>FGF23_HUMAN</name>
<protein>
<recommendedName>
<fullName>Fibroblast growth factor 23</fullName>
<shortName>FGF-23</shortName>
</recommendedName>
<alternativeName>
<fullName>Phosphatonin</fullName>
</alternativeName>
<alternativeName>
<fullName>Tumor-derived hypophosphatemia-inducing factor</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Fibroblast growth factor 23 N-terminal peptide</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Fibroblast growth factor 23 C-terminal peptide</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">FGF23</name>
<name type="synonym">HYPF</name>
<name type="ORF">UNQ3027/PRO9828</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="277" first="494" last="498">
<title>Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.</title>
<authorList>
<person name="Yamashita T."/>
<person name="Yoshioka M."/>
<person name="Itoh N."/>
</authorList>
<dbReference type="PubMed" id="11032749"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3696"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Nat. Genet." volume="26" first="345" last="348">
<title>Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.</title>
<authorList>
<person name="White K.E."/>
<person name="Evans W.E."/>
<person name="O'Riordan J.L.H."/>
<person name="Speer M.C."/>
<person name="Econs M.J."/>
<person name="Lorenz-Depiereux B."/>
<person name="Grabowski M."/>
<person name="Meitinger T."/>
<person name="Strom T.M."/>
</authorList>
<dbReference type="PubMed" id="11062477"/>
<dbReference type="DOI" id="10.1038/81664"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>VARIANTS ADHR GLN-176; GLN-179 AND TRP-179</scope>
<scope>VARIANT MET-239</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="6500" last="6505">
<title>Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.</title>
<authorList>
<person name="Shimada T."/>
<person name="Mizutani S."/>
<person name="Muto T."/>
<person name="Yoneya T."/>
<person name="Hino R."/>
<person name="Takeda S."/>
<person name="Takeuchi Y."/>
<person name="Fujita T."/>
<person name="Fukumoto S."/>
<person name="Yamashita T."/>
</authorList>
<dbReference type="PubMed" id="11344269"/>
<dbReference type="DOI" id="10.1073/pnas.101545198"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2004-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-195 AND MET-239</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="284" first="977" last="981">
<title>FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.</title>
<authorList>
<person name="Bowe A.E."/>
<person name="Finnegan R."/>
<person name="Jan de Beur S.M."/>
<person name="Cho J."/>
<person name="Levine M.A."/>
<person name="Kumar R."/>
<person name="Schiavi S.C."/>
</authorList>
<dbReference type="PubMed" id="11409890"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5084"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT ADHR GLN-179</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="497" last="500">
<title>The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.</title>
<authorList>
<person name="White K.E."/>
<person name="Jonsson K.B."/>
<person name="Carn G."/>
<person name="Hampson G."/>
<person name="Spector T.D."/>
<person name="Mannstadt M."/>
<person name="Lorenz-Depiereux B."/>
<person name="Miyauchi A."/>
<person name="Yang I.M."/>
<person name="Ljunggren O."/>
<person name="Meitinger T."/>
<person name="Strom T.M."/>
<person name="Jueppner H."/>
<person name="Econs M.J."/>
</authorList>
<dbReference type="PubMed" id="11157998"/>
<dbReference type="DOI" id="10.1210/jcem.86.2.7408"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Endocrinology" volume="143" first="3179" last="3182">
<title>Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.</title>
<authorList>
<person name="Shimada T."/>
<person name="Muto T."/>
<person name="Urakawa I."/>
<person name="Yoneya T."/>
<person name="Yamazaki Y."/>
<person name="Okawa K."/>
<person name="Takeuchi Y."/>
<person name="Fujita T."/>
<person name="Fukumoto S."/>
<person name="Yamashita T."/>
</authorList>
<dbReference type="PubMed" id="12130585"/>
<dbReference type="DOI" id="10.1210/endo.143.8.8795"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Clin. Invest." volume="112" first="683" last="692">
<title>FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.</title>
<authorList>
<person name="Riminucci M."/>
<person name="Collins M.T."/>
<person name="Fedarko N.S."/>
<person name="Cherman N."/>
<person name="Corsi A."/>
<person name="White K.E."/>
<person name="Waguespack S."/>
<person name="Gupta A."/>
<person name="Hannon T."/>
<person name="Econs M.J."/>
<person name="Bianco P."/>
<person name="Gehron Robey P."/>
</authorList>
<dbReference type="PubMed" id="12952917"/>
<dbReference type="DOI" id="10.1172/jci200318399"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Bone" volume="35" first="455" last="462">
<title>FGF23 is processed by proprotein convertases but not by PHEX.</title>
<authorList>
<person name="Benet-Pages A."/>
<person name="Lorenz-Depiereux B."/>
<person name="Zischka H."/>
<person name="White K.E."/>
<person name="Econs M.J."/>
<person name="Strom T.M."/>
</authorList>
<dbReference type="PubMed" id="15268897"/>
<dbReference type="DOI" id="10.1016/j.bone.2004.04.002"/>
</citation>
<scope>PROTEOLYTIC PROCESSING BY PROPROTEIN CONVERTASES</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Bone Miner. Res." volume="19" first="429" last="435">
<title>FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.</title>
<authorList>
<person name="Shimada T."/>
<person name="Hasegawa H."/>
<person name="Yamazaki Y."/>
<person name="Muto T."/>
<person name="Hino R."/>
<person name="Takeuchi Y."/>
<person name="Fujita T."/>
<person name="Nakahara K."/>
<person name="Fukumoto S."/>
<person name="Yamashita T."/>
</authorList>
<dbReference type="PubMed" id="15040831"/>
<dbReference type="DOI" id="10.1359/jbmr.0301264"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15694" last="15700">
<title>Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.</title>
<authorList>
<person name="Zhang X."/>
<person name="Ibrahimi O.A."/>
<person name="Olsen S.K."/>
<person name="Umemori H."/>
<person name="Mohammadi M."/>
<person name="Ornitz D.M."/>
</authorList>
<dbReference type="PubMed" id="16597617"/>
<dbReference type="DOI" id="10.1074/jbc.m601252200"/>
</citation>
<scope>INTERACTION WITH FGFR1; FGFR2; FGFR3 AND FGFR4</scope>
<scope>FUNCTION IN STIMULATION OF CELL PROLIFERATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="18370" last="18377">
<title>Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.</title>
<authorList>
<person name="Kato K."/>
<person name="Jeanneau C."/>
<person name="Tarp M.A."/>
<person name="Benet-Pages A."/>
<person name="Lorenz-Depiereux B."/>
<person name="Bennett E.P."/>
<person name="Mandel U."/>
<person name="Strom T.M."/>
<person name="Clausen H."/>
</authorList>
<dbReference type="PubMed" id="16638743"/>
<dbReference type="DOI" id="10.1074/jbc.m602469200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION AT THR-178</scope>
<scope>CHARACTERIZATION OF VARIANTS ADHR GLN-176 AND GLN-179</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Bone Miner. Res." volume="23" first="939" last="948">
<title>Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.</title>
<authorList>
<person name="Wang H."/>
<person name="Yoshiko Y."/>
<person name="Yamamoto R."/>
<person name="Minamizaki T."/>
<person name="Kozai K."/>
<person name="Tanne K."/>
<person name="Aubin J.E."/>
<person name="Maeda N."/>
</authorList>
<dbReference type="PubMed" id="18282132"/>
<dbReference type="DOI" id="10.1359/jbmr.080220"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Nat. Rev. Cancer" volume="10" first="116" last="129">
<title>Fibroblast growth factor signalling: from development to cancer.</title>
<authorList>
<person name="Turner N."/>
<person name="Grose R."/>
</authorList>
<dbReference type="PubMed" id="20094046"/>
<dbReference type="DOI" id="10.1038/nrc2780"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="3417" last="3428">
<title>Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.</title>
<authorList>
<person name="Goetz R."/>
<person name="Beenken A."/>
<person name="Ibrahimi O.A."/>
<person name="Kalinina J."/>
<person name="Olsen S.K."/>
<person name="Eliseenkova A.V."/>
<person name="Xu C."/>
<person name="Neubert T.A."/>
<person name="Zhang F."/>
<person name="Linhardt R.J."/>
<person name="Yu X."/>
<person name="White K.E."/>
<person name="Inagaki T."/>
<person name="Kliewer S.A."/>
<person name="Yamamoto M."/>
<person name="Kurosu H."/>
<person name="Ogawa Y."/>
<person name="Kuro-o M."/>
<person name="Lanske B."/>
<person name="Razzaque M.S."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="17339340"/>
<dbReference type="DOI" id="10.1128/mcb.02249-06"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 25-179</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Hum. Genet." volume="118" first="261" last="266">
<title>A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification.</title>
<authorList>
<person name="Chefetz I."/>
<person name="Heller R."/>
<person name="Galli-Tsinopoulou A."/>
<person name="Richard G."/>
<person name="Wollnik B."/>
<person name="Indelman M."/>
<person name="Koerber F."/>
<person name="Topaz O."/>
<person name="Bergman R."/>
<person name="Sprecher E."/>
<person name="Schoenau E."/>
</authorList>
<dbReference type="PubMed" id="16151858"/>
<dbReference type="DOI" id="10.1007/s00439-005-0026-8"/>
</citation>
<scope>VARIANT HFTC2 THR-96</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="385" last="390">
<title>An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.</title>
<authorList>
<person name="Benet-Pages A."/>
<person name="Orlik P."/>
<person name="Strom T.M."/>
<person name="Lorenz-Depiereux B."/>
</authorList>
<dbReference type="PubMed" id="15590700"/>
<dbReference type="DOI" id="10.1093/hmg/ddi034"/>
</citation>
<scope>VARIANT HFTC2 GLY-71</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="5523" last="5527">
<title>A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.</title>
<authorList>
<person name="Araya K."/>
<person name="Fukumoto S."/>
<person name="Backenroth R."/>
<person name="Takeuchi Y."/>
<person name="Nakayama K."/>
<person name="Ito N."/>
<person name="Yoshii N."/>
<person name="Yamazaki Y."/>
<person name="Yamashita T."/>
<person name="Silver J."/>
<person name="Igarashi T."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="16030159"/>
<dbReference type="DOI" id="10.1210/jc.2005-0301"/>
</citation>
<scope>VARIANT HFTC2 PHE-129</scope>
<scope>CHARACTERIZATION OF VARIANT HFTC2 PHE-129</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="Gene" volume="542" first="269" last="271">
<title>A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS).</title>
<authorList>
<person name="Abbasi F."/>
<person name="Ghafouri-Fard S."/>
<person name="Javaheri M."/>
<person name="Dideban A."/>
<person name="Ebrahimi A."/>
<person name="Ebrahim-Habibi A."/>
</authorList>
<dbReference type="PubMed" id="24680727"/>
<dbReference type="DOI" id="10.1016/j.gene.2014.03.052"/>
</citation>
<scope>VARIANT HFTC2 LEU-157</scope>
</reference>
<comment type="function">
<text evidence="3 4 5 7 12 14">Regulator of phosphate homeostasis. Inhibits renal tubular phosphate transport by reducing SLC34A1 levels. Upregulates EGR1 expression in the presence of KL (By similarity). Acts directly on the parathyroid to decrease PTH secretion (By similarity). Regulator of vitamin-D metabolism. Negatively regulates osteoblast differentiation and matrix mineralization.</text>
</comment>
<comment type="subunit">
<text evidence="3">Interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) and their receptors is increased by KL and heparan sulfate glycosaminoglycans that function as coreceptors (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6594125">
<id>Q9GZV9</id>
</interactant>
<interactant intactId="EBI-1028277">
<id>P11362</id>
<label>FGFR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6594125">
<id>Q9GZV9</id>
</interactant>
<interactant intactId="EBI-1570828">
<id>O35082</id>
<label>Kl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13">Secreted</location>
</subcellularLocation>
<text>Secretion is dependent on O-glycosylation.</text>
</comment>
<comment type="tissue specificity">
<text evidence="6">Expressed in osteogenic cells particularly during phases of active bone remodeling. In adult trabecular bone, expressed in osteocytes and flattened bone-lining cells (inactive osteoblasts).</text>
</comment>
<comment type="PTM">
<text>Following secretion this protein is inactivated by cleavage into a N-terminal fragment and a C-terminal fragment. The processing is effected by proprotein convertases.</text>
</comment>
<comment type="PTM">
<text evidence="13">O-glycosylated by GALT3. Glycosylation is necessary for secretion; it blocks processing by proprotein convertases when the O-glycan is alpha 2,6-sialylated. Competition between proprotein convertase cleavage and block of cleavage by O-glycosylation determines the level of secreted active FGF23.</text>
</comment>
<comment type="disease" evidence="4 5 13">
<disease id="DI-01212">
<name>Hypophosphatemic rickets, autosomal dominant</name>
<acronym>ADHR</acronym>
<description>A disease characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D3 (calcitriol) levels. Patients frequently present with bone pain, rickets, and tooth abscesses.</description>
<dbReference type="MIM" id="193100"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="9 10 11 15">
<disease id="DI-05253">
<name>Tumoral calcinosis, hyperphosphatemic, familial, 2</name>
<acronym>HFTC2</acronym>
<description>A form of hyperphosphatemic tumoral calcinosis, a rare autosomal recessive metabolic disorder that manifests with hyperphosphatemia and massive calcium deposits in the skin and subcutaneous tissues. Some patients have recurrent, transient, painful swellings of the long bones associated with the radiographic findings of periosteal reaction and cortical hyperostosis and absence of skin involvement.</description>
<dbReference type="MIM" id="617993"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the heparin-binding growth factors family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/fgf23/"/>
</comment>
<dbReference type="EMBL" id="AB037973">
<property type="protein sequence ID" value="BAB13477.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF263537">
<property type="protein sequence ID" value="AAG09917.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB047858">
<property type="protein sequence ID" value="BAB55889.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358323">
<property type="protein sequence ID" value="AAQ88689.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY566236">
<property type="protein sequence ID" value="AAS59157.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069333">
<property type="protein sequence ID" value="AAH69333.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096713">
<property type="protein sequence ID" value="AAH96713.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098147">
<property type="protein sequence ID" value="AAH98147.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098252">
<property type="protein sequence ID" value="AAH98252.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8526.1"/>
<dbReference type="RefSeq" id="NP_065689.1">
<property type="nucleotide sequence ID" value="NM_020638.2"/>
</dbReference>
<dbReference type="PDB" id="2P39">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=25-179"/>
</dbReference>
<dbReference type="PDB" id="5W21">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B=25-204"/>
</dbReference>
<dbReference type="PDB" id="6S22">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="F=170-181"/>
</dbReference>
<dbReference type="PDBsum" id="2P39"/>
<dbReference type="PDBsum" id="5W21"/>
<dbReference type="PDBsum" id="6S22"/>
<dbReference type="SMR" id="Q9GZV9"/>
<dbReference type="BioGRID" id="113748">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="CORUM" id="Q9GZV9"/>
<dbReference type="DIP" id="DIP-58507N"/>
<dbReference type="IntAct" id="Q9GZV9">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000237837"/>
<dbReference type="ChEMBL" id="CHEMBL3713913"/>
<dbReference type="TCDB" id="1.A.108.1.2">
<property type="family name" value="the fibroblast growth factor 2 (fgf2) family"/>
</dbReference>
<dbReference type="GlyGen" id="Q9GZV9">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9GZV9"/>
<dbReference type="PhosphoSitePlus" id="Q9GZV9"/>
<dbReference type="BioMuta" id="FGF23"/>
<dbReference type="DMDM" id="13626688"/>
<dbReference type="PaxDb" id="Q9GZV9"/>
<dbReference type="PeptideAtlas" id="Q9GZV9"/>
<dbReference type="PRIDE" id="Q9GZV9"/>
<dbReference type="ProteomicsDB" id="80160"/>
<dbReference type="ABCD" id="Q9GZV9">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="22263">
<property type="antibodies" value="476 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000237837">
<property type="protein sequence ID" value="ENSP00000237837"/>
<property type="gene ID" value="ENSG00000118972"/>
</dbReference>
<dbReference type="GeneID" id="8074"/>
<dbReference type="KEGG" id="hsa:8074"/>
<dbReference type="UCSC" id="uc001qmq.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8074"/>
<dbReference type="DisGeNET" id="8074"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000118972.1"/>
<dbReference type="GeneCards" id="FGF23"/>
<dbReference type="GeneReviews" id="FGF23"/>
<dbReference type="HGNC" id="HGNC:3680">
<property type="gene designation" value="FGF23"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000118972">
<property type="expression patterns" value="Tissue enhanced (blood, heart muscle, liver, urinary bladder)"/>
</dbReference>
<dbReference type="MalaCards" id="FGF23"/>
<dbReference type="MIM" id="193100">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="605380">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617993">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9GZV9"/>
<dbReference type="OpenTargets" id="ENSG00000118972"/>
<dbReference type="Orphanet" id="89937">
<property type="disease" value="Autosomal dominant hypophosphatemic rickets"/>
</dbReference>
<dbReference type="Orphanet" id="306661">
<property type="disease" value="Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28119"/>
<dbReference type="eggNOG" id="KOG3885">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160821"/>
<dbReference type="HOGENOM" id="CLU_094251_0_0_1"/>
<dbReference type="InParanoid" id="Q9GZV9"/>
<dbReference type="KO" id="K22428"/>
<dbReference type="OMA" id="DDCLFNH"/>
<dbReference type="OrthoDB" id="1345259at2759"/>
<dbReference type="PhylomeDB" id="Q9GZV9"/>
<dbReference type="TreeFam" id="TF335872"/>
<dbReference type="PathwayCommons" id="Q9GZV9"/>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839122">
<property type="pathway name" value="Signaling by activated point mutants of FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839130">
<property type="pathway name" value="Signaling by activated point mutants of FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190322">
<property type="pathway name" value="FGFR4 ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190372">
<property type="pathway name" value="FGFR3c ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190373">
<property type="pathway name" value="FGFR1c ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190374">
<property type="pathway name" value="FGFR1c and Klotho ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190375">
<property type="pathway name" value="FGFR2c ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2033514">
<property type="pathway name" value="FGFR3 mutant receptor activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2033519">
<property type="pathway name" value="Activated point mutants of FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654219">
<property type="pathway name" value="Phospholipase C-mediated cascade: FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654221">
<property type="pathway name" value="Phospholipase C-mediated cascade, FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654227">
<property type="pathway name" value="Phospholipase C-mediated cascade, FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654228">
<property type="pathway name" value="Phospholipase C-mediated cascade, FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654687">
<property type="pathway name" value="Downstream signaling of activated FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654688">
<property type="pathway name" value="SHC-mediated cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654689">
<property type="pathway name" value="PI-3K cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654693">
<property type="pathway name" value="FRS-mediated FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654695">
<property type="pathway name" value="PI-3K cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654699">
<property type="pathway name" value="SHC-mediated cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654700">
<property type="pathway name" value="FRS-mediated FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654704">
<property type="pathway name" value="SHC-mediated cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654706">
<property type="pathway name" value="FRS-mediated FGFR3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654710">
<property type="pathway name" value="PI-3K cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654712">
<property type="pathway name" value="FRS-mediated FGFR4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654719">
<property type="pathway name" value="SHC-mediated cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654720">
<property type="pathway name" value="PI-3K cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654726">
<property type="pathway name" value="Negative regulation of FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654727">
<property type="pathway name" value="Negative regulation of FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654732">
<property type="pathway name" value="Negative regulation of FGFR3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654733">
<property type="pathway name" value="Negative regulation of FGFR4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655253">
<property type="pathway name" value="Signaling by FGFR2 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5658623">
<property type="pathway name" value="FGFRL1 modulation of FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853338">
<property type="pathway name" value="Signaling by FGFR3 point mutants in cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9GZV9"/>
<dbReference type="BioGRID-ORCS" id="8074">
<property type="hits" value="1 hit in 874 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9GZV9"/>
<dbReference type="GeneWiki" id="Fibroblast_growth_factor_23"/>
<dbReference type="GenomeRNAi" id="8074"/>
<dbReference type="Pharos" id="Q9GZV9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9GZV9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q9GZV9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000118972">
<property type="expression patterns" value="Expressed in sural nerve and 35 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9GZV9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005796">
<property type="term" value="C:Golgi lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008083">
<property type="term" value="F:growth factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005105">
<property type="term" value="F:type 1 fibroblast growth factor receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030643">
<property type="term" value="P:cellular phosphate ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071354">
<property type="term" value="P:cellular response to interleukin-6"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044320">
<property type="term" value="P:cellular response to leptin stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071374">
<property type="term" value="P:cellular response to parathyroid hormone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071305">
<property type="term" value="P:cellular response to vitamin D"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030502">
<property type="term" value="P:negative regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046888">
<property type="term" value="P:negative regulation of hormone secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045668">
<property type="term" value="P:negative regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055062">
<property type="term" value="P:phosphate ion homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090080">
<property type="term" value="P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010980">
<property type="term" value="P:positive regulation of vitamin D 24-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010966">
<property type="term" value="P:regulation of phosphate transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032026">
<property type="term" value="P:response to magnesium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904383">
<property type="term" value="P:response to sodium phosphate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042369">
<property type="term" value="P:vitamin D catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00058">
<property type="entry name" value="FGF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR028304">
<property type="entry name" value="FGF23"/>
</dbReference>
<dbReference type="InterPro" id="IPR002209">
<property type="entry name" value="Fibroblast_GF_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR008996">
<property type="entry name" value="IL1/FGF"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11486">
<property type="entry name" value="PTHR11486"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11486:SF69">
<property type="entry name" value="PTHR11486:SF69"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00167">
<property type="entry name" value="FGF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00442">
<property type="entry name" value="FGF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50353">
<property type="entry name" value="SSF50353"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0339">Growth factor</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Fibroblast growth factor 23" id="PRO_0000008998">
<location>
<begin position="25"/>
<end position="251"/>
</location>
</feature>
<feature type="chain" description="Fibroblast growth factor 23 N-terminal peptide" id="PRO_0000352875">
<location>
<begin position="25"/>
<end position="179"/>
</location>
</feature>
<feature type="chain" description="Fibroblast growth factor 23 C-terminal peptide" id="PRO_0000352876">
<location>
<begin position="180"/>
<end position="251"/>
</location>
</feature>
<feature type="site" description="Cleavage; by proprotein convertases">
<location>
<begin position="179"/>
<end position="180"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc) threonine" evidence="13">
<location>
<position position="178"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="95"/>
<end position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In HFTC2; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex; dbSNP:rs104894342." id="VAR_023831" evidence="9">
<original>S</original>
<variation>G</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In HFTC2; dbSNP:rs104894343." id="VAR_071711" evidence="11">
<original>M</original>
<variation>T</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In HFTC2; full-length and N-terminal fragments are barely detectable, whereas a C-terminal fragment with the same molecular weight as that from wild-type can be detected; dbSNP:rs104894344." id="VAR_071712" evidence="10">
<original>S</original>
<variation>F</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In HFTC2; dbSNP:rs772964687." id="VAR_071713" evidence="15">
<original>F</original>
<variation>L</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In ADHR; partially resistant to cleavage by furin; dbSNP:rs104894347." id="VAR_010717" evidence="4 13">
<original>R</original>
<variation>Q</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In ADHR; C-terminal processing is abolished; reduced proteolysis by PHEX; resistant to cleavage by furin; dbSNP:rs193922702." id="VAR_010719" evidence="4 5 13">
<original>R</original>
<variation>Q</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In ADHR; C-terminal processing is abolished; dbSNP:rs28937882." id="VAR_010718" evidence="4">
<original>R</original>
<variation>W</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13312793." id="VAR_018887" evidence="16">
<original>P</original>
<variation>S</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7955866." id="VAR_010720" evidence="4 16">
<original>T</original>
<variation>M</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="32"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="47"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="66"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="73"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="87"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="92"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="153"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="157"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P39"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5W21"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11062477"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11409890"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12952917"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15040831"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590700"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16030159"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16151858"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16597617"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16638743"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18282132"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24680727"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="251" mass="27954" checksum="6093BD0CC50C2489" modified="2001-03-01" version="1" precursor="true">MLGARLRLWVCALCSVCSMSVLRAYPNASPLLGSSWGGLIHLYTATARNSYHLQIHKNGHVDGAPHQTIYSALMIRSEDAGFVVITGVMSRRYLCMDFRGNIFGSHYFDPENCRFQHQTLENGYDVYHSPQYHFLVSLGRAKRAFLPGMNPPPYSQFLSRRNEIPLIHFNTPIPRRHTRSAEDDSERDPLNVLKPRARMTPAPASCSQELPSAEDNSPMASDPLGVVRGGRVNTHAGGTGPEGCRPFAKFI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

